Thursday, 8 October 2026
Pfizer submits vitiligo data for oral drug approval
Exam Preps

Pfizer submits vitiligo data for oral drug approval

Pfizer submits oral drug Litfulo data for nonsegmental vitiligo approval, a condition affecting about 70 million people worldwide.

By Sintya Dewi  •  03/10/2026
IL-17 Inhibitors Show Low IBD Risk in HS Patients
Test Tips

IL-17 Inhibitors Show Low IBD Risk in HS Patients

IL-17 inhibitors show low IBD risk in HS patients, according to a recent review in JAMA Dermatology.

By Reva Kusumah  •  21/09/2026
Hidradenitis suppurativa linked to lymphoma risk
Mock Tests

Hidradenitis suppurativa linked to lymphoma risk

New research indicates a link between hidradenitis suppurativa and lymphoma risk. A 2019 study found patients were two to four…

By Reva Kusumah  •  17/09/2026